NCT07376603

IMRT Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features

Intensity-Modulated Radiotherapy Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 169 (estimated)
• Sponsor: Qiaojuan Guo · Other Government
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

This observational study aims to evaluate the efficacy and safety of intensity-modulated radiotherapy (IMRT) alone in patients with stage IB nasopharyngeal carcinoma (NPC) without high-risk features. The primary objective is to determine the therapeutic effectiveness of this approach

Conditions

• Nasopharyngeal Cancinoma (NPC)
• Intensity-modulated Radiotherapy
• Stage IB

Interventions

Type	Name	Description
RADIATION	IMRT along	All patients administered with definitive radiotherapy

Timeline

• Start date: 2026-01-12
• Primary completion: 2030-12-31
• Completion: 2030-12-31
• First posted: 2026-01-29
• Last updated: 2026-01-29

Locations

1 site across 1 country: China